Möchten Sie immer auf dem neuesten Stand bleiben?

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

WILMINGTON, Del., Jan. 16, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that the company has signed a...

COMMUNIQUE DE PRESSE – INFORMATION PRIVILIGIEE Un nouveau contrat a été signé pour adapter les termes de deux accords précédents en vertu desquels Phebra a accordé à Medsenic SAS, une...

PRESS RELEASE – INSIDE INFORMATION BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation of arsenic troxide...

SAN JOSE, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the company whose patented innovations shape the way the world explores and experiences entertainment, today announced...

CORNELIUS, N.C., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Modus, Corp. (“Alpha Modus”), a technology company with a core focus on artificial intelligence in retail, today announced it has entered...

3-year agreement to January 7, 2027 The agreement ensures operational continuity at MVC VANCOUVER, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX:...

WILMINGTON, Del., Jan. 10, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that the company has renewed...

Vivos Therapeutics is seeing positive preliminary metrics regarding FDA 510(k) clearance of its CARE oral medical devices to treat severe OSA.

BOSTON and CHENGDU, China, Jan. 08, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, and...